Zdrowie i gospodarka · 23/03/2020

Blood Products Advisory Committee Meeting Postponed Due to COVID-19

The FDA has postponed the Blood Products Advisory Committee meeting originally scheduled for April 2-3, 2020, as part of efforts to ensure the agency's preparedness for the COVID-19 public health emergency.